Skip to main content
. 2024 Sep 15;16(9):4867–4875. doi: 10.62347/QQEI5676

Table 2.

Pathological diagnosis results from liver biopsy

Item CHB [n (%)] NAFLD [n (%)] AFLD [n (%)] ALD [n (%)] DILI [n (%)] HBC [n (%)]
Clinical diagnosis 92 (63.01%) 6 (4.11%) 3 (2.05%) 16 (10.96%) 22 (15.07%) 7 (4.79%)
Concordance rate between clinical and pathological diagnosis 82.61% (76/92) 83.33% (5/6) 66.67% (2/3) 75% (12/16) 72.72% (16/22) 71.43% (5/7)

Note: CHB, chronic hepatitis B; NAFLD, non-alcoholic fatty liver disease; AFLD, alcoholic fatty liver disease; ALD, autoimmune liver disease; DILI, Drug-induced liver injury; HBC, hepatitis B-related cirrhosis.